| Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317) |
|---|
| 08/02/2000 | EP1023898A1 Cyano-indoles as serotonine reuptake inhibitors and as 5-HT2c receptor ligands |
| 08/02/2000 | EP1023897A2 Dermal agent |
| 08/02/2000 | EP1023447A1 Human ribonuclease a with reduced ribonuclease inhibitor affinity |
| 08/02/2000 | EP1023444A1 Cell division regulators |
| 08/02/2000 | EP1023441A1 Models and treatments for cardiac hypertrophy in relation with nf-at3 function |
| 08/02/2000 | EP1023323A1 Novel vitamin d receptor related polypeptides, nucleic acid sequence encoding the same and uses thereof |
| 08/02/2000 | EP1023318A1 Dipeptides for the treatment of diseases related to the biological effect of endothelin |
| 08/02/2000 | EP1023316A2 Methods and compositions for lipidization of hydrophilic molecules |
| 08/02/2000 | EP1023315A1 Methods and compositions for destruction of selected proteins |
| 08/02/2000 | EP1023314A1 Bile acid salts of metals with physiological action and the use thereof in therapy |
| 08/02/2000 | EP1023313A1 Inhibition of stress activated protein kinase (sapk) pathway and sensitization of cells to cancer therapies |
| 08/02/2000 | EP1023308A1 Inhibitors of nucleoside metabolism |
| 08/02/2000 | EP1023299A1 Combined generation of phosphinic acid derivatives |
| 08/02/2000 | EP1023296A1 3-substituted pyrido 3',4':4,5] thieno 2,3-d] pyrimidine derivatives, and production and use of the same |
| 08/02/2000 | EP1023295A1 Fibrinogen receptor antagonist prodrugs |
| 08/02/2000 | EP1023290A1 Synthesis of swainsonine salts |
| 08/02/2000 | EP1023288A1 Stereochemical control of the dna binding affinity, sequence specificity, and orientation-preference of chiral hairpin polyamides in the minor groove |
| 08/02/2000 | EP1023287A1 3-oxo-2(h)-1,2,4-triazine derivatives as ligands of 5ht1a receptors |
| 08/02/2000 | EP1023286A1 Benzimidazole compounds, pharmaceutical compositions containing the compounds and their use |
| 08/02/2000 | EP1023285A1 Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 08/02/2000 | EP1023273A1 Cyclohexane derivatives difunctionalised in 1,4 as ligands of 5t h1a receptors |
| 08/02/2000 | EP1023269A1 Beta3-adrenoreceptor agonists, agonist compositions and methods of using |
| 08/02/2000 | EP1023268A1 Isoquinolines as urokinase inhibitors |
| 08/02/2000 | EP1023266A2 Process for making diaryl pyridines useful as cox-2 inhibitors |
| 08/02/2000 | EP1023085A1 Human embryonic germ cell line and methods of use |
| 08/02/2000 | EP1023081A1 Use of recombinant human uteroglobin in treatment of inflammatory and fibrotic conditions |
| 08/02/2000 | EP1023080A1 Ligand binding site of rage and uses thereof |
| 08/02/2000 | EP1023072A1 Analgesic compositions |
| 08/02/2000 | EP1023068A1 ALPHA 1a ADRENERGIC RECEPTOR ANTAGONISTS |
| 08/02/2000 | EP1023067A2 The use of inhibitors of the renin-angiotensin system for the treatment of hypoxia or impaired metabolic function |
| 08/02/2000 | EP1023066A1 Novel pyrazole and pyrazoline substituted compounds |
| 08/02/2000 | EP1023063A1 INDENO 1,2-c]-, NAPHTHO 1,2-c]- AND BENZO 6,7]CYCLOHEPTA 1,2-c]PYRAZOLE DERIVATIVES |
| 08/02/2000 | EP1023061A1 Somatostatin agonists |
| 08/02/2000 | EP1023060A1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS |
| 08/02/2000 | EP1022945A2 Method and formulation for treating vascular disease |
| 08/02/2000 | EP0819129B1 Pyrazole derivatives and processes for the preparation thereof |
| 08/02/2000 | EP0729325A4 Osteogenic product and process |
| 08/02/2000 | EP0613373B1 Risedronate delayed-release compositions |
| 08/02/2000 | CN1261895A Cyclic azapeptide with angiogenic effect |
| 08/02/2000 | CN1261887A Azetidinyl propylpiperidine derivatives, intermediates and use as tachykinin antagonists |
| 08/02/2000 | CN1261886A Polymorphs of 8-chloro-6,11-dihydro-11-(4-piperdylidene)-5H-benzo [5,6] cyclohepta [1,2-b] pyridine |
| 08/02/2000 | CN1261885A 2-substituted 4,5-diaryl imidazoles |
| 08/02/2000 | CN1261882A Polymorphic form of tachykinin receptor antagonist 2-(R)-(1-(R)-(3,5-bis(trifluoromethyl) phenyl) ethoxy)-3-(S)-(4-fluoro) phenyl-4-(3-5(oxo-1H,4H-1,2,4-triazolo methylmorpholine |
| 08/02/2000 | CN1261881A 6-azauracil derivatives as IL-5 inhibitors |
| 08/02/2000 | CN1261880A Inhibitors of farnesyl protein transferase |
| 08/02/2000 | CN1261878A New cysteine derivatives processes for their production, and pharmaceuticals containing them |
| 08/02/2000 | CN1261877A 4-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitors |
| 08/02/2000 | CN1261876A N-hydroxyformamide derivatives as inhibitors of matrix metalloproteinases |
| 08/02/2000 | CN1261808A Improved method for transferring nucleic acid into multicelled eukaryotic organism cells and combination therefor |
| 08/02/2000 | CN1261807A Improved method for transferring nucleic acid into the striped muscle and combination therefor |
| 08/02/2000 | CN1261803A Antioxidant enhancement of therapy for hyperproliferative conditions |
| 08/02/2000 | CN1261801A Allelic polygene diagnosis of reward deficiency syndrome and treatment |
| 08/02/2000 | CN1261799A Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin |
| 08/02/2000 | CN1261795A Compounds and methods |
| 08/02/2000 | CN1261792A Gelatine encapsulated solution dosage forms of sertraline |
| 08/02/2000 | CN1261534A Medicinal composition containing naphthyl compound |
| 08/02/2000 | CN1055089C Intermediate of protein kinase C inhibitor and its preparation |
| 08/02/2000 | CN1055017C Medicine for treating hernia and its producing method |
| 08/02/2000 | CN1055011C Method for preparing fresh preparation of mother wort |
| 08/02/2000 | CN1055007C Chinese herbal medicine capsule for curing saccular mastoproliferation |
| 08/01/2000 | US6096897 Endothelin receptor antagonists |
| 08/01/2000 | US6096873 Mitogen polypeptide; for the treatment of nervous system and muscular disorders; anticarcinogenic agents |
| 08/01/2000 | US6096864 Tetrapeptide for the treatment of injuries |
| 08/01/2000 | US6096787 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 08/01/2000 | US6096778 α-ketoamide multicatalytic protease inhibitors |
| 08/01/2000 | US6096777 Method for inhibiting the expression of Fas |
| 08/01/2000 | US6096773 Inhibitor of binding of integrin to its receptors, such as (vascular cell adhesion molecule-1) and fibronectin and useful for controlling the diseases induced by binding |
| 08/01/2000 | US6096766 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 08/01/2000 | US6096764 Eliminating the detrimental side-effects associated with the continuous and chronic use of gondatropin-releasing hormone factor or agonist by administering to the patient an effective amount of benzothiophene derivatives |
| 08/01/2000 | US6096762 Contacting nerve cells with a neurotrophic amount of difluoroamide compound with affinity for an fk-506 binding protein for stimulating neurite grwoth in nerve cells |
| 08/01/2000 | US6096749 Pyrrolopyrimidine derivatives having pharmacological activity |
| 08/01/2000 | US6096748 Pyrimidine compounds useful in treating cytokine mediated diseases |
| 08/01/2000 | US6096745 Imidazolone anorectic agents: III. heteroaryl derivatives |
| 08/01/2000 | US6096739 Treatment for CNS injuries |
| 08/01/2000 | US6096735 Benzoheterocyclic derivatives |
| 08/01/2000 | US6096724 O(6)-alkylguanine-dna alkyltransferase (atase) enzyme inhibitors |
| 08/01/2000 | US6096712 Tripeptide derivative; antiallergens, male contraceptives, antiinflammatory agents, antispasmodics, hypertensive agents |
| 08/01/2000 | US6096709 Use of angiotensin II fragments and analogs thereof in tissue repair |
| 08/01/2000 | US6096527 Nucleic acids encoding protein tryosine kinases |
| 08/01/2000 | US6096517 Human kidney sodium bicarbonate transporter (HNBC1A) polynucleotides |
| 08/01/2000 | US6096513 Amino acid sequences; for screening agonists and antagonists; for analgesics |
| 08/01/2000 | US6096308 Human protein kinase and kinase inhibitors |
| 08/01/2000 | CA2217260C Use of vitamin d2 or vitamin d4-derivatives for the manufacture of a medicament for the treatment of secondary hyperparathyroidism |
| 08/01/2000 | CA2199845C Quinoxalinedione nmda receptor antagonists |
| 08/01/2000 | CA2189250C Cytokine regulatory agents and methods of use in pathologies and conditions associated with altered cytokine levels |
| 08/01/2000 | CA2158058C Biologically active peptides from functional domains of bactericidal/permeability-increasing protein and uses thereof |
| 08/01/2000 | CA2134240C Novel peptide having elastase inhibitor activity and process for producing the same |
| 08/01/2000 | CA2066640C Heterocyclic compounds |
| 08/01/2000 | CA2019335C Phenylalkan (en)oic acids |
| 08/01/2000 | CA2015034C Piperazine derivatives |
| 08/01/2000 | CA2006322C Recombinant dna molecules, hosts, processes and human somatomedin carrier protein-like polypeptides |
| 07/29/2000 | CA2290771A1 Azithromycin combination for emesis control in dogs |
| 07/28/2000 | CA2297464A1 Pharmaceutical preparation for the treatment of inflammatory processes |
| 07/27/2000 | WO2000043553A1 Identifying, monitoring, and treating women for breast precancer or cancer |
| 07/27/2000 | WO2000043511A1 Polypeptide |
| 07/27/2000 | WO2000043503A1 Improved phytases |
| 07/27/2000 | WO2000043501A2 Ribozymes directed against the catalytic subunit of the human telomerase (htert) |
| 07/27/2000 | WO2000043495A2 33 human secreted proteins |
| 07/27/2000 | WO2000043435A1 Ionic molecular conjugates of biodegradable polyesters and bioactive polypeptides |
| 07/27/2000 | WO2000043419A2 Exocytosis pathway proteins and methods of use |